or Try an Advanced Search...

    ETF Components for EWL - iShares MSCI Switzerland Capped Index Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVS D -0.07 13.26
    ABBV A -0.07 4.44

    Represented by ETF Holdings

    Keywords: Eye Care Products Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Antibiotics Atopic Dermatitis Autoimmune Disease Biotechnology Blood Cancers Blood Test Chronic Idiopathic Constipation Combination Drugs Constipation Contact Lens Contact Lenses Crohn's Disease Depressive Disorder
    Industries: Drug Manufacturers - Major

    Recent News for iShares MSCI Switzerland Capped Index Fund & its Holdings

    Date Stock Title
    Oct 2 ABBV AbbVie: $200 Peak (Rating Downgrade)
    Oct 2 NVS Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
    Oct 2 ABBV AbbVie's Skyrizi And Rinvoq Deserve The Premium Growth Valuation
    Oct 2 ABBV Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing
    Oct 2 ABBV 5 Best Dividend Growth Stocks to Buy in October
    Oct 2 ABBV Blue Shield of California sidesteps PBMs with new Humira biosimilar deal
    Oct 2 ABBV Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
    Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
    Oct 1 NVS US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
    Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
    Oct 1 NVS Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
    Oct 1 ABBV AbbVie to Host Third-Quarter 2024 Earnings Conference Call
    Sep 30 NVS Top Research Reports for Apple, Tesla & T-Mobile US
    Sep 30 NVS Novartis: Value Continues To Build With Double-Digit Percentage Growth Products
    Sep 30 ABBV AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
    Sep 30 ABBV AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
    Sep 30 ABBV Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
    Sep 30 NVS Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
    Sep 30 ABBV Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
    Sep 30 ABBV 15 Best Dividend Stocks for Lifelong Passive Income
    The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The MSCI Switzerland 25/50 Index consists of stocks traded primarily on the Zurich Stock Exchange. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the MSCI Switzerland 25/50 Index. The fund is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds MSCI EAFE
    Back to the Main EWL Page...